Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Brinavess Approved in South Africa | Contract Pharma

What are you searching for?

Sign in
Trials & Filings

Brinavess Approved in South Africa

MCC clears treatment for atrial fibrillation

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Cardiome Pharma Corp. has received approval from South Africa’s Medicines Control Council (MCC) for Brinavess for the rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults.

“Cardiome is pleased with the approval of Brinavess in South Africa,” said Karim Lalji, Cardiome’s chief commercial officer. “We are committed to partnering Brinavess in this important pharmaceutical market as we continue to focus Cardiome’s direct sales efforts on key countries in Europe.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics